Physician

Matthew Martini, M.D

According to 2025 Medicare claims, Matthew Martini, M.D (NPI: 1184087462) practices interventional radiology in the Kenosha, WI market, with the plurality of this provider's patient population coming from Kenosha, WI. This provider's primary affiliated billing organization is FROEDTERT SOUTH, INC. (NPI: 1558305284; TIN: 390816845) and primary practice location at 53158-1984.

Martini's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 440 traditional Medicare patients, billed 997 HCPCS/CPT codes, and received $39,346 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 365 prescription claims across 136 beneficiaries totaling $58,381 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 26 records totaling $2,256. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,471 to $58,381. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$20K$39K2024 Medicare payment: $39,346 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024440997$39,346

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$29K$58K2018 Drug cost: $2,471 (USD; Tot_Drug_Cst)2019 Drug cost: $2,716 (USD; Tot_Drug_Cst)2022 Drug cost: $385 (USD; Tot_Drug_Cst)2023 Drug cost: $5,167 (USD; Tot_Drug_Cst)2024 Drug cost: $58,381 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181229$2,471
2019N/R23$2,716
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R19$385
2023N/R18$5,167
2024136365$58,381

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7275$94
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function9999$51
93016Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician5050$16
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report99106$11
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only226284$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban20973$19,057
Metoprolol SuccinateMetoprolol Succinate503,473$782
Losartan PotassiumLosartan Potassium251,568$264
IrbesartanIrbesartan242,160$227
Rosuvastatin CalciumRosuvastatin Calcium231,950$222

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$2,256Edwards Lifesciences Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Martini, M.D?

Tedicare shows public-source Medicare data for Matthew Martini, M.D (NPI 1184087462), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Martini, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Martini, M.D?

Matthew Martini, M.D is linked to FROEDTERT SOUTH, INC. (billing NPI 1558305284) in the available physician profile data.

Does Matthew Martini, M.D have Open Payments data?

Matthew Martini, M.D has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.